Membranous glomerulonephritis: a step forward in B-cell targeting therapy?

Nephrol Dial Transplant. 2020 Apr 1;35(4):549-551. doi: 10.1093/ndt/gfz139.

Authors

Karine Dahan^{1

2}, Jean-Jacques Boffa^{1

3}

Affiliations

¹ Department of Nephrology and Dialysis, AP-HP, Hôpital Tenon, Paris, France.
² CRMR, Centre de référence maladies rares « Syndrome Néphrotique Idiopathique de l'Enfant et de l'Adulte », Hôpital Tenon, Paris, France.
³ INSERM, UMR_S 1155, Paris, France.

PMID: 31377779
DOI: 10.1093/ndt/gfz139

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
B-Lymphocytes
Glomerulonephritis, Membranous*
Humans
Proteinuria
Receptors, Phospholipase A2

Substances

Antibodies, Monoclonal, Humanized
Receptors, Phospholipase A2
belimumab